Deerfield Management Company, L.P. 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Deerfield Management Company, L.P. disclosed 124 US equity positions worth $5.5bn in its Q2 2025 13F filing. The largest position was NUVALENT INC at 24.9% of the reported book, followed by OSCR and VTRS. Against the Q1 2025 filing, it opened 5 new positions, added to 19 and reduced 8 among the top 50 holdings.
What did Deerfield Management Company, L.P. own in Q2 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | NUVALENT INC | 24.9% | $1.4bn | 17,991,024 | 0% | held | |
| 2 | OSCR OSCAR HEALTH INC | Healthcare | 4.5% | $249.8m | 11,649,591 | -2% | reduced |
| 3 | VTRS VIATRIS INC | Healthcare | 3.9% | $214.5m | 24,023,907 | 0% | held |
| 4 | MERUS N V | 3.2% | $178.0m | 3,384,628 | 7% | added | |
| 5 | CNC CENTENE CORP DEL | Healthcare | 3.1% | $172.9m | 3,185,370 | 19% | added |
| 6 | INTEGRA LIFESCIENCES HLDGS C | 3.1% | $172.9m | 174,364,000 | 0% | held | |
| 7 | SPRY ARS PHARMACEUTICALS INC | Healthcare | 3.1% | $169.7m | 9,724,508 | -8% | reduced |
| 8 | INDIVIOR PLC | 2.8% | $155.8m | 10,567,160 | 0% | held | |
| 9 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 2.8% | $155.3m | 540,626 | 96% | added |
| 10 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.7% | $146.8m | 1,167,802 | -22% | reduced |
| 11 | ALNY ALNYLAM PHARMACEUTICALS INC | 2.6% | $143.2m | 110,000,000 | 0% | held | |
| 12 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.3% | $124.5m | 3,384,072 | 2% | added |
| 13 | MIRM MIRUM PHARMACEUTICALS INC | 2.3% | $124.2m | 70,000,000 | 0% | held | |
| 14 | BKD BROOKDALE SR LIVING INC | Healthcare | 1.9% | $106.9m | 15,362,264 | -2% | reduced |
| 15 | LEGN LEGEND BIOTECH CORP | Healthcare | 1.9% | $105.1m | 2,962,338 | 70% | added |
| 16 | PFE PFIZER INC | Healthcare | 1.9% | $104.4m | 4,306,264 | 29% | added |
| 17 | AHCO ADAPTHEALTH CORP | Healthcare | 1.7% | $93.4m | 9,904,895 | 2% | added |
| 18 | NEWAMSTERDAM PHARMA COMPANY | 1.7% | $92.6m | 5,115,953 | 25% | added | |
| 19 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 1.5% | $82.3m | 3,915,311 | 20% | added |
| 20 | VERA VERA THERAPEUTICS INC | Healthcare | 1.4% | $78.9m | 3,348,117 | 219% | added |
| 21 | INSM INSMED INC | Healthcare | 1.3% | $70.5m | 700,700 | 53% | added |
| 22 | MRK MERCK & CO INC | Healthcare | 1.2% | $67.9m | 857,724 | – | new |
| 23 | CATALYST PHARMACEUTICALS INC | 1.1% | $62.5m | 2,879,476 | -16% | reduced | |
| 24 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 1.1% | $61.4m | 21,231,974 | 0% | held |
| 25 | BAX BAXTER INTL INC | Healthcare | 1.1% | $58.2m | 1,923,100 | 0% | held |
| 26 | BIO BIO RAD LABS INC | Healthcare | 1.0% | $54.6m | 226,070 | 0% | held |
| 27 | IRON DISC MEDICINE INC | Healthcare | 0.9% | $48.7m | 919,403 | 18% | added |
| 28 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.9% | $47.3m | 145,000 | 0% | held |
| 29 | ENHABIT INC | 0.8% | $46.1m | 4,779,864 | -4% | reduced | |
| 30 | CERT CERTARA INC | Healthcare | 0.8% | $45.9m | 3,926,099 | 94% | added |
| 31 | NVST ENVISTA HOLDINGS CORPORATION | Healthcare | 0.8% | $43.3m | 2,215,845 | 9% | added |
| 32 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.8% | $42.0m | 4,692,000 | -10% | reduced |
| 33 | TNDM TANDEM DIABETES CARE INC | 0.7% | $38.5m | 40,000,000 | – | new | |
| 34 | CNMD CONMED CORP | Healthcare | 0.7% | $36.5m | 700,271 | 15% | added |
| 35 | PHVS PHARVARIS N V | 0.6% | $35.5m | 2,017,464 | 0% | held | |
| 36 | LANTHEUS HLDGS INC | 0.6% | $32.1m | 25,255,000 | 0% | held | |
| 37 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 0.5% | $29.0m | 3,855,552 | -0% | held |
| 38 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.5% | $28.9m | 686,931 | 11% | added |
| 39 | PHR PHREESIA INC | Healthcare | 0.5% | $28.9m | 1,014,577 | 0% | held |
| 40 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 0.5% | $28.5m | 653,000 | 10% | added |
| 41 | MRNA MODERNA INC | Healthcare | 0.5% | $27.6m | 1,000,000 | – | new |
| 42 | EWTX EDGEWISE THERAPEUTICS INC | 0.5% | $27.1m | 2,067,320 | -1% | reduced | |
| 43 | EMBC EMBECTA CORP | Healthcare | 0.5% | $26.6m | 2,749,712 | 1% | added |
| 44 | IMMUNOCORE HLDGS PLC | 0.5% | $25.8m | 30,000,000 | 0% | held | |
| 45 | LIVANOVA PLC | 0.5% | $25.4m | 25,000,000 | – | new | |
| 46 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.4% | $24.2m | 3,723,131 | 26% | added | |
| 47 | VTR VENTAS INC | Real Estate | 0.4% | $22.4m | 354,000 | – | new |
| 48 | LQDA LIQUIDIA CORPORATION | Healthcare | 0.4% | $20.1m | 1,616,778 | 0% | held |
| 49 | COGT COGENT BIOSCIENCES INC | Healthcare | 0.3% | $19.0m | 2,640,215 | 0% | held |
| 50 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.3% | $18.2m | 6,710,429 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.